Outcomes of discontinuing rivaroxaban compared with warfarin in patients with nonvalvular atrial fibrillation: analysis from the ROCKET AF trial (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation)
Patel, Hellkamp, Lokhnygina, Piccini, Zhang, Mohanty, Singer, Hacke, Breithardt, Halperin, Hankey, Becker, Nessel, Berkowitz, Califf, Fox, Mahaffey (2013) Outcomes of discontinuing rivaroxaban compared with warfarin in patients with nonvalvular atrial fibrillation: analysis from the ROCKET AF trial (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation) J Am Coll Cardiol (IF: 21.7) 61(6) 651-8Links
http://www.ncbi.nlm.nih.gov/pubmed/23391196http://dx.doi.org/10.1016/j.jacc.2012.09.057
